ATE273021T1 - Gereinigtes vakuolisierendes toxin aus helicobacter pylori und methoden zu dessen verwendung - Google Patents

Gereinigtes vakuolisierendes toxin aus helicobacter pylori und methoden zu dessen verwendung

Info

Publication number
ATE273021T1
ATE273021T1 AT93906142T AT93906142T ATE273021T1 AT E273021 T1 ATE273021 T1 AT E273021T1 AT 93906142 T AT93906142 T AT 93906142T AT 93906142 T AT93906142 T AT 93906142T AT E273021 T1 ATE273021 T1 AT E273021T1
Authority
AT
Austria
Prior art keywords
toxin
methods
purified
helicobacter pylori
vacuolizing
Prior art date
Application number
AT93906142T
Other languages
English (en)
Inventor
Timothy L Cover
Martin J Blaser
Original Assignee
Univ Vanderbilt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Vanderbilt filed Critical Univ Vanderbilt
Application granted granted Critical
Publication of ATE273021T1 publication Critical patent/ATE273021T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/121—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Helicobacter (Campylobacter) (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)
AT93906142T 1992-02-26 1993-02-24 Gereinigtes vakuolisierendes toxin aus helicobacter pylori und methoden zu dessen verwendung ATE273021T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84164492A 1992-02-26 1992-02-26
PCT/US1993/001558 WO1993016723A1 (en) 1992-02-26 1993-02-24 Purified vacuolating toxin from helicobacter pylori and methods to use same

Publications (1)

Publication Number Publication Date
ATE273021T1 true ATE273021T1 (de) 2004-08-15

Family

ID=25285365

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93906142T ATE273021T1 (de) 1992-02-26 1993-02-24 Gereinigtes vakuolisierendes toxin aus helicobacter pylori und methoden zu dessen verwendung

Country Status (8)

Country Link
US (2) US6054132A (de)
EP (1) EP0629132B1 (de)
JP (3) JP3920320B2 (de)
AT (1) ATE273021T1 (de)
AU (1) AU3728293A (de)
CA (1) CA2117490C (de)
DE (1) DE69333585T2 (de)
WO (1) WO1993016723A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721349A (en) * 1992-02-26 1998-02-24 Vanderbilt University Vacuolating toxin-deficient H. pylori
US5859219A (en) * 1992-02-26 1999-01-12 Vanderbilt University Purified vacuolating toxin from Helicobacter pylori and methods to use same
EP0629132B1 (de) * 1992-02-26 2004-08-11 Vanderbilt University Gereinigtes vakuolisierendes toxin aus helicobacter pylori und methoden zu dessen verwendung
US7141244B1 (en) * 1992-03-02 2006-11-28 Chiron Srl Helicobacter pylori proteins useful for vaccines and diagnostics
MX9301706A (es) * 1992-04-13 1994-05-31 Oravax Inc Composicion de vacuna para el tratamiento de la infeccion por helicobacter.
US6290962B1 (en) * 1992-11-03 2001-09-18 Oravax, Inc. Urease-based vaccine and treatment for helicobacter infection
US6258359B1 (en) 1993-05-19 2001-07-10 Institut Pasteur Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions, and nucleic acid sequences encoding said polypeptides
WO1995014093A1 (en) 1993-05-19 1995-05-26 Institut Pasteur Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions and nucleic acid sequences encoding said polypeptides
US6406703B1 (en) 1993-07-27 2002-06-18 Csl Limited Treatment of H. pylori associated gastroduodenal disease
WO1995003824A1 (en) * 1993-07-27 1995-02-09 Csl Limited Treatment of h. pylori associated gastroduodenal disease
AUPM612494A0 (en) 1994-06-08 1994-06-30 Csl Limited Treatment or prevention of helicobacter infection
GB2290710B (en) * 1994-06-29 1998-03-25 Reckitt & Colmann Prod Ltd Protease from helicobacter pylori for use in vaccines/therapeutic compositions
ATE229978T1 (de) * 1994-07-01 2003-01-15 Chiron Corp Helicobacter proteine und impstoffe
GB9422331D0 (en) * 1994-11-04 1994-12-21 Biocine Spa H. pylori fermentation process
AU1463097A (en) 1996-01-04 1997-08-01 Rican Limited Helicobacter pylori bacterioferritin
EP0918858A1 (de) 1996-05-10 1999-06-02 Biogen, Inc. Agenzien, die die gemeinsame gamma-kette blockieren
US6902903B1 (en) * 1996-12-19 2005-06-07 Chiron Corporation Helicobacter pylori diagnostics
GB9807721D0 (en) * 1998-04-08 1998-06-10 Chiron Spa Antigen
JP4346821B2 (ja) 1998-04-30 2009-10-21 カイロン ソチエタ ア レスポンサビリタ リミタータ Ｈ．Ｐｙｌｏｒｉによる感染に対する免疫化および処置
FI20010019A (fi) * 2001-01-05 2002-07-06 Biohit Oyj Menetelmä atrofisen diagnostisoimiseksi
EP1373566B1 (de) * 2001-04-02 2009-08-12 Point-2-Point Genomics Ltd. Analyse von polynukleotiden mittels kombinatorischer pcr
WO2003018054A1 (en) * 2001-08-31 2003-03-06 Chiron Srl. Helicobacter pylori vaccination
US20030224401A1 (en) * 2002-02-19 2003-12-04 The Regents Of The University Of California Proteins for helicobacter diagnosis
US8647640B2 (en) * 2009-06-24 2014-02-11 Richard E. COWART Vaccine compositions and methods of use to protect against infectious disease

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459041A (en) * 1988-02-18 1995-10-17 Enteric Research Laboratories, Inc. Campylobacter pylori antigens and uses thereof for detection of Campylobacter pylori infection
US4882271A (en) * 1988-03-10 1989-11-21 Baylor College Of Medicine Process for preparation of high molecular weight cell-associated protein of campylobacter pylori and use for serological detection of campylobacter pylori infection
GB2223756A (en) * 1988-09-29 1990-04-18 Health Lab Service Board Protein purification process
AU644121B2 (en) * 1989-12-04 1993-12-02 Auspharm International Limited Rapid in vitro test for helicobacter pylori using saliva
US5567594A (en) * 1991-04-26 1996-10-22 Enteron, L.P. Methods and compositions for the detection and treatment of diseases associated with antigens of microorganisms
US5262156A (en) * 1991-08-12 1993-11-16 Hycor Biomedical, Inc. Antigenic compositions and their use for the detection of Helicobacter pylori
US5721349A (en) * 1992-02-26 1998-02-24 Vanderbilt University Vacuolating toxin-deficient H. pylori
EP0629132B1 (de) * 1992-02-26 2004-08-11 Vanderbilt University Gereinigtes vakuolisierendes toxin aus helicobacter pylori und methoden zu dessen verwendung
EP0967279B1 (de) * 1992-03-02 2008-01-02 Novartis Vaccines and Diagnostics S.r.l. Helicobacter pylori Cytotoxin verwendbar in Impfstoffe und Diagnostik
MX9301706A (es) * 1992-04-13 1994-05-31 Oravax Inc Composicion de vacuna para el tratamiento de la infeccion por helicobacter.
IT1258182B (it) * 1992-08-12 1996-02-20 Composizioni contenenti bafilomycina per l'inibizione di vacuolizzazione indotta da helicobacter pylori
US5403924A (en) * 1992-10-13 1995-04-04 Vanderbilt University Taga gene and methods for detecting predisposition to peptic ulceration

Also Published As

Publication number Publication date
CA2117490A1 (en) 1993-09-02
DE69333585D1 (de) 2004-09-16
US6013463A (en) 2000-01-11
US6054132A (en) 2000-04-25
JP3920320B2 (ja) 2007-05-30
EP0629132B1 (de) 2004-08-11
DE69333585T2 (de) 2005-07-28
JP2004043469A (ja) 2004-02-12
CA2117490C (en) 2009-01-06
JPH07507444A (ja) 1995-08-24
EP0629132A1 (de) 1994-12-21
WO1993016723A1 (en) 1993-09-02
JP2005320335A (ja) 2005-11-17
AU3728293A (en) 1993-09-13
EP0629132A4 (de) 1997-02-26

Similar Documents

Publication Publication Date Title
ATE273021T1 (de) Gereinigtes vakuolisierendes toxin aus helicobacter pylori und methoden zu dessen verwendung
DE69333110D1 (de) Mit dem cytotoxin von helicobacter pylori assoziiertes, immunodominantes antigen verwendbar in impfstoffen und zur diagnose
FR2631708B1 (fr) Dispositif permettant d'effectuer des mesures ou des interventions dans un puits, methode utilisant le dispositif et applications du dispositif
NO893769D0 (no) Fremgangsmaate for behandling av naturgass.
PT804737E (pt) Metodo de avaliacao dos riscos do cancro gastrico
NO910373D0 (no) Fremgangsmaate for behandling av underjordiske formasjonerved anvendelse av et ikke-oedeleggende fraktureringsfluid.
DK388384A (da) Monoklone antistoffer med specifitet for membran-associerede antigener, deres fremstilling og anvendelse
NO903944L (no) Fremgangsmaate for fremstilling av nye peptidase og isomerase-inhibitorer.
ATE220688T1 (de) Tumor-zerstörende effekte von enterotoxinen und verwandten verbindungen
DE68919101T2 (de) Gasabschaltungsvorrichtung.
DE69504959T2 (de) Humanisierte monoklonale antikörper gegen humanes interleukin - 4
DE68921908T2 (de) Zell-assoziierte Glucosyltransferase, Antikörper dagegen und eine diese enthaltende Zusammensetzung zur Prophylaxe von Karies.
ATE280229T1 (de) Enterotoxine von shigella flexneri 2a
ATE144286T1 (de) Monoklonale antikörper gegen den plasmin- antiplasmin komplex, verfahren zu ihrer herstellung sowie ihre verwendung
SU630136A1 (ru) Устройство дл ст гивани ленты
ATE206138T1 (de) Helicobacter pylori antigen
NO881683L (no) Fremgangsmaate og innretning for perforering av broennboringer under utnyttelse av differensialtrykk.
SU572590A1 (ru) Струйный усилитель
SU855196A1 (ru) Устройство дл перекрыти скважины
NO890123D0 (no) Innretning for bruk av roerledninger.
NO169196C (no) Anordning for styring og lukking av gass-stroemmer.
DK161098C (da) Antistoffer mod modificeret beta2-mikroglobulin, fremgangsmaader til detektering af modificeret beta2-mikroglobulin samt farmaceutiske praeparater indeholdende saadanne antistoffer
NO156423C (no) Rÿrhÿndteringsanordning for forflytting av rÿr, spesielt borerÿr og foringsrÿr.
DK362087D0 (da) Method for a rapid and sensitive detection of early appearing antibodies against retroviruses, as well as igg antibodies against certain retroviruses
NO883836L (no) Fremgangsmaate for rehabilitering av roersystemer.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0629132

Country of ref document: EP

REN Ceased due to non-payment of the annual fee